Rett patients receive a new gene therapy treatment at Texas Children’s Hospital and Baylor College of Medicine
Nearly 25 years after the discovery that mutations in MECP2 gene cause Rett syndrome, the first gene therapy trial for this difficult-to-treat condition is underway.
Read More